2013
DOI: 10.1007/s10151-013-1054-3
|View full text |Cite
|
Sign up to set email alerts
|

Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn’s disease who refused colonoscopy or underwent incomplete colonoscopic exam: a case series

Abstract: In this patient population, PillCam(®) COLON 2 capsule endoscopy was safe. The capsule findings had an important impact on treatment decisions and patient management.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(24 citation statements)
references
References 21 publications
0
23
0
1
Order By: Relevance
“…CD tends to involve the terminal ileum and colon, and approximately 60% of patients with established CD have proximal small bowel lesions. 21,22 Several reports [23][24][25][26][27] assessed the role of CCE-2 in pan-enteric examinations for CD. D'Haens et al 23 compared CCE-2 and colonoscopy to assess disease severity in 40 patients with active colonic CD.…”
Section: Cce For Crohn's Diseasementioning
confidence: 99%
“…CD tends to involve the terminal ileum and colon, and approximately 60% of patients with established CD have proximal small bowel lesions. 21,22 Several reports [23][24][25][26][27] assessed the role of CCE-2 in pan-enteric examinations for CD. D'Haens et al 23 compared CCE-2 and colonoscopy to assess disease severity in 40 patients with active colonic CD.…”
Section: Cce For Crohn's Diseasementioning
confidence: 99%
“…To date, five studies have evaluated the performance of CCE‐2 with ileo‐colonoscopy or small bowel CE in suspected or confirmed CD (Table ). There are also studies that evaluated the role of CCE in routine clinical practice without comparing with a reference standard, in postoperative CD, and in CD patients who refused or had incomplete colonoscopy . The first multicenter European study has reported that CCE‐2 has a comparable sensitivity of 86% but a low specificity of 40% for ileo‐colonic ulceration in active CD .…”
Section: Cce In CDmentioning
confidence: 99%
“…However, whether CCE is superior to conventional colonoscopy for assessment of disease activity and extent in UC remains controversial [34]. Although literature on use of CCE in Crohn's disease (CD) is sparse due to the concern of capsule retention caused by strictures, more recent studies demonstrate the safety and feasibility of use of CE in this disease [38][39][40][41][42]. In a multicenter pilot study, CCE-2 detected colonic ulcerations with 86 % sensitivity and 40 % specificity, and no adverse events were observed.…”
Section: Cce In Ibdmentioning
confidence: 99%